Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis
- 9 May 2005
- journal article
- Published by Springer Nature in Oncogene
- Vol. 24 (38) , 5799-5808
- https://doi.org/10.1038/sj.onc.1208738
Abstract
MUC1 is an integral membrane mucin glycoprotein that is normally expressed on the apical surface of most simple, secretory epithelia and hematopoietic cells. Overexpression of aberrantly glycosylated MUC1 is a hallmark of many carcinomas including 90% of breast carcinomas. MUC1 has been shown to bind to c-Src tyrosine kinase in vitro, whereby c-Src phosphorylates the MUC1 cytoplasmic domain at a YEKV motif. c-Src is an extensively studied nonreceptor tyrosine kinase implicated in mammary tumorigenesis. Previously, mouse mammary tumor virus-driven polyoma middle T-antigen (MMTV-PyV MT) transgenic mice crossed onto a Muc1 null background exhibited a significant delay in tumor progression. c-Src has been shown to interact with PyV MT, and to play an integral and indispensable role in MMTV-PyV MT-induced mammary tumorigenesis. Here, we determine the effect of Muc1 expression on c-Src activation and signaling. Examination of MMTV-PyV MT glands on a wild-type or Muc1 null background demonstrates that Muc1 expression promotes c-Src signaling by influencing its association with known substrates such as the p85 subunit of phosphatidylinositol 3-kinase and -catenin. These findings may provide a mechanism for the delay in tumor progression that is observed in the absence of Muc1.Keywords
This publication has 42 references indexed in Scilit:
- MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiationOncogene, 2004
- STAT proteins: From normal control of cellular events to tumorigenesisJournal of Cellular Physiology, 2003
- MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasionOncogene, 2003
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- The Human DF3/MUC1 Carcinoma-Associated Antigen Signals Nuclear Localization of the Catenin p120ctnBiochemical and Biophysical Research Communications, 2001
- STAT proteins: novel molecular targets for cancer drug discoveryOncogene, 2000
- A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.Molecular Biology of the Cell, 1996
- Delayed Mammary Tumor Progression in Muc-1 Null MiceJournal of Biological Chemistry, 1995
- Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins Cytokine receptor‐like moleculesFEBS Letters, 1994
- An 81 kd protein complexed with middle T antigen and pp60c-src: A possible phosphatidylinositol kinaseCell, 1987